KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $211,000 | -42.0% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $364,000 | +2.5% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $355,000 | -35.1% | 36,200 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $547,000 | +6.2% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | +219.9% | 36,200 | +120.7% | 0.00% | +100.0% |
| Q3 2019 | $161,000 | -19.9% | 16,400 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $201,000 | -52.0% | 32,800 | +65.7% | 0.00% | -50.0% |
| Q1 2019 | $419,000 | +175.7% | 19,800 | +20.7% | 0.00% | +100.0% |
| Q4 2018 | $152,000 | -63.7% | 16,400 | -17.2% | 0.00% | -50.0% |
| Q3 2018 | $419,000 | +21.8% | 19,800 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $344,000 | +27.9% | 20,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $269,000 | +100.7% | 20,300 | +31.0% | 0.00% | 0.0% |
| Q1 2016 | $134,000 | -44.9% | 15,500 | -14.8% | 0.00% | -33.3% |
| Q4 2015 | $243,000 | +27.9% | 18,200 | +1.1% | 0.00% | +50.0% |
| Q3 2015 | $190,000 | -59.7% | 18,000 | +4.0% | 0.00% | -66.7% |
| Q2 2015 | $471,000 | -7.8% | 17,300 | +3.6% | 0.01% | 0.0% |
| Q1 2015 | $511,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |